DrugPrices

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

America's Medicine Cabinet: Unpacking the Tariffs Debate and Our Global Drug Reliance

The Cost Conundrum: Unpacking Massachusetts' Sky-High Healthcare Bills

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Global Turmoil Squeezes India's Pharma: Drugmakers Plead for Input Price Caps

The Uncharted Alliance: Klotho Neurosciences Forges Unexpected Path with Greenland Mining Giant

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

An Unexpected Turn: America's Drug Price Paradox

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

The Cost of Cures: Unpacking America's Enduring Drug Price Predicament

Unpacking the Ambition: Trump's Most-Favored-Nation Drug Pricing Push

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A New Era for Drug Prices: How Medicare's Negotiation Power is Reshaping Healthcare

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Evolving Landscape of Biotech Innovation and Investment

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

A Grand Bargain for Health? The Looming Question of Obesity Drugs and Who Pays.

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Ghost in the Machine: How Trump's Drug Price Transparency Memo Almost Changed Everything—But Didn't

The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

Trump Unleashes Trade Weapon Against Global Partners Over 'Unfair' Drug Prices

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement